Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimization of treatment of iron deficiency anemia secondary to acute gastrointestinal bleeding (intravenous vs oral iron)
2009-016847-20Phase 4Terminated
- Sponsor
- Health Research Institute Hospital La Fe
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ferric carboxymaltose and ferrous glycinate sulfate in iron deficiency anemia (IDA) (2 arms), sponsored by Health Research Institute Hospital La Fe. Primary endpoint: Rate of patients achieving hemoglobin normalization. Started Nov 2009; status: terminated.
02
Drugs
ferric carboxymaltoseferrous glycinate sulfate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2009-016847-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016847-20.